ArticleJournal for immunotherapy of cancer2021

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.

Kim E Kortekaas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.